A large number of studies have shown that ELK1 can be used as a cancer protein for many human cancers, including pancreatic cancer [45, 46], colorectal cancer [47, 48], gastric cancer [49], lung cancer [50], and nasopharyngeal carcinoma [51]. The gene discussed is ELK1; the disease is nasopharyngeal carcinoma.